Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant

International Immunology

Volumn 23, Issue 5, 2011, Pages 327-334

  Li, Jing ^a   Guo, JunXia ^a   Su, ZhenYi ^a   Hu, MinLing ^a   Liu, Wei ^a   Wei, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Adjuvant; Calcineurin subunit B; Cytokines; Dendritic cells

Indexed keywords

CALCINEURIN; CANCER VACCINE; CELL MARKER; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MESSENGER RNA; OVALBUMIN; PHOSPHATE BUFFERED SALINE; RECOMBINANT CALCINEURIN SUBUNIT B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CANCER IMMUNIZATION; CELL ACTIVATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; TUMOR IMMUNITY;

EID: 79955518857     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr008     Document Type: Article

References (43)

1. Schijns, V. E. 2003. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine 21:829.
2. Heit, A., Busch, D. H., Wagner, H. and Schmitz, F. 2008. Vaccine protocols for enhanced immunogenicity of exogenous antigens. Int. J. Med. Microbiol. 298:27.
3. Guy, B. 2010. Strategies to improve the effect of vaccination in the elderly: the vaccine producer's perspective. J. Comp. Pathol. 142(Suppl 1):S133.
4. El Sahly, H. 2010. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. Expert Rev. Vaccines 9:1135.
5. Sun, Y., Liu, J., Yu, H. and Gong, C. 2010. Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions. Int. Immunopharmacol. 10:584.
6. Ivory, C. P., Keller, K. and Chadee, K. 2006. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Galinhibitable lectin vaccine against amoebic liver abscess in gerbils. Infect. Immun. 74:528.
7. McAleer, J. P. and Vella, A. T. 2008. Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit. Rev. Immunol. 28:281.
8. Coler, R. N., Baldwin, S. L., Shaverdian, N. et al. 2010. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One 5:e13677.
9. Giddings, O. K., Eickhoff, C. S., Sullivan, N. L. and Hoft, D. F. 2010. Intranasal vaccinations with the trans-sialidase antigen plus CpG adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infect. Immun. 78:1333.
10. Yamamoto, S. 2010. [CpG motif and tuberculosis immunity]. Kekkaku 85:515.
11. Stern, B. V., Boehm, B. O. and Tary-Lehmann, M. 2002. Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. J. Immunol. 168:6099.
12. Rosenkrands, I., Agger, E. M., Olsen, A. W. et al. 2005. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect. Immun. 73:5817.
13. Cluff, C. W. 2009. Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. Adv. Exp. Med. Biol. 667:111.
14. Honko, A. N., Sriranganathan, N., Lees, C. J. and Mizel, S. B. 2006. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 74:1113.
15. Kumar, M., Behera, A. K., Hu, J., Lockey, R. F. and Mohapatra, S. S. 2001. IFN-gamma and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy. J. Allergy Clin. Immunol. 108:402.
16. Tovey, M. G. and Lallemand, C. 2010. Adjuvant activity of cytokines. Methods Mol. Biol. 626:287.
17. Wan, T., Zhou, X., Chen, G. et al. 2004. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103:1747.
18. Zhang, X., Yu, C., Zhao, J. et al. 2007. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice. J. Gene Med. 9:715.
19. Gamvrellis, A., Leong, D., Hanley, J. C., Xiang, S. D., Mottram, P. and Plebanski, M. 2004. Vaccines that facilitate antigen entry into dendritic cells. Immunol. Cell Biol. 82:506.
20. Neurath, M. F., Finotto, S. and Glimcher, L. H. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567.
21. Gupta, R. K. and Siber, G. R. 1995. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13:1263.
22. Langermans, J. A., Schmidt, A., Vervenne, R. A. et al. 2005. Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques. Vaccine 23:4935.
23. Quan, Z., Qin, Z.G., Zhen, W., Feng, X.Z., Hong, J. and Fei, Z. H. 2010. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine. Vet. Immunol. Immunopathol. 136:257.
24. Rajput, Z. I., Hu, S. H., Xiao, C. W. and Arijo, A. G. 2007. Adjuvant effects of saponins on animal immune responses. J. Zhejiang Univ. Sci. B 8:153.
25. Wang, D., Hu, Y., Sun, J., Kong, X., Zhang, B. and Liu, J. 2005. Comparative study on adjuvanticity of compound Chinese herbal medicinal ingredients. Vaccine 23:3704.
26. Greenblatt, M. B., Aliprantis, A., Hu, B. and Glimcher, L. H. 2010. Calcineurin regulates innate antifungal immunity in neutrophils. J. Exp. Med. 207:923.
27. Li, C., Liang, J., Ma, Z. et al. 2010. Calcineurin mediates the immune response of hemocytes through NF-kappaB signaling pathway in pearl oyster (Pinctada fucata). Fish Shellfish Immunol. 28:253.
28. Baine, I., Abe, B. T. and Macian, F. 2009. Regulation of T-cell tolerance by calcium/NFAT signaling. Immunol. Rev. 231:225.
29. Shibasaki, F., Hallin, U. and Uchino, H. 2002. Calcineurin as a multifunctional regulator. J. Biochem. 131:1.
30. Jin, F. Z., Lian, M. L., Wang, X. and Wei, Q. 2005. Studies of the anticancer effect of calcineurin B Immunopharmacol. Immunotoxicol. 27:199.
31. Lutz, M. B., Kukutsch, N., Ogilvie, A. L. et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77.
32. Sempowski, G. D., Cross, S. J., Heinly, C. S., Scearce, R. M. and Haynes, B. F. 2004. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis. J. Immunol. 172:787.
33. Rescigno, M. and Di Sabatino, A. 2009. Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest. 119:2441.
34. Trevejo, J. M., Marino, M. W., Philpott, N. et al. 2001. TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc. Natl Acad. Sci. U S A 98:12162.
35. Moser, B. and Loetscher, P. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:123.
36. Wu, Y., Wan, T., Zhou, X. et al. 2005. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. Cancer Res. 65:4947.
37. Zhang, N., Wang, Z., Tang, X. et al. 2010. Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response. Cell. Mol. Immunol. 7:355.
38. Nicholls, E. F., Madera, L. and Hancock, R. E. 2010. Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Ann. N. Y. Acad. Sci. 1213:46-61.
39. Gurunathan, S., Prussin, C., Sacks, D. L. and Seder, R. A. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4:1409.
40. Pertl, U., Luster, A. D., Varki, N. M. et al. 2001. IFN-gammainducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J. Immunol. 166:6944.
41. Yoshimura, S., Bondeson, J., Foxwell, B. M., Brennan, F. M. and Feldmann, M. 2001. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 13:675.
42. Kawai, T. and Akira, S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317.
43. Ohmura, M., Yamamoto, M., Tomiyama-Miyaji, C., Yuki, Y., Takeda, Y. and Kiyono, H. 2005. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Infect. Immun. 73:4088.